QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
NASDAQ:SCPH

scPharmaceuticals - SCPH Stock Forecast, Price & News

$7.12
-0.21 (-2.86%)
(As of 12/1/2022 12:00 AM ET)
Add
Compare
Today's Range
$7.12
$7.70
50-Day Range
$4.02
$7.53
52-Week Range
$3.48
$7.96
Volume
401,884 shs
Average Volume
156,216 shs
Market Capitalization
$195.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.25

scPharmaceuticals MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
150.5% Upside
$17.83 Price Target
Short Interest
Healthy
3.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.97
Upright™ Environmental Score
News Sentiment
0.68mentions of scPharmaceuticals in the last 14 days
Based on 12 Articles This Week
Insider Trading
Acquiring Shares
$4 M Bought Last Quarter
Proj. Earnings Growth
Decreasing
From ($1.47) to ($1.78) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.57 out of 5 stars

Medical Sector

398th out of 1,047 stocks

Pharmaceutical Preparations Industry

167th out of 512 stocks

SCPH stock logo

About scPharmaceuticals (NASDAQ:SCPH) Stock

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Receive SCPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for scPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SCPH Stock News Headlines

See More Headlines
Receive SCPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for scPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SCPH Company Calendar

Last Earnings
11/09/2022
Today
12/01/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/28/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SCPH
Fax
N/A
Employees
26
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$17.83
High Stock Price Forecast
$25.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+100.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-28,030,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.13 per share

Miscellaneous

Free Float
26,145,000
Market Cap
$195.33 million
Optionable
Not Optionable
Beta
0.15

Key Executives

  • Mr. John H. Tucker (Age 59)
    Pres, CEO, Principal Exec. Officer, Principal Financial Officer & Director
    Comp: $856.52k
  • Ms. Rachael Nokes (Age 47)
    Sr. VP of Fin. & Principal Accounting Officer
    Comp: $498.09k
  • Katherine Taudvin
    Director of Corp. Devel. & Investor Relations
  • Dr. John Mohr Pharm.D.
    Sr. VP of Clinical Devel. & Medical Affairs
  • Mr. Michael D. Hassman
    Sr. VP of Technical Operations













SCPH Stock - Frequently Asked Questions

Should I buy or sell scPharmaceuticals stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for scPharmaceuticals in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SCPH shares.
View SCPH analyst ratings
or view top-rated stocks.

What is scPharmaceuticals' stock price forecast for 2023?

6 brokers have issued 1-year price objectives for scPharmaceuticals' stock. Their SCPH share price forecasts range from $12.00 to $25.00. On average, they anticipate the company's share price to reach $17.83 in the next twelve months. This suggests a possible upside of 150.5% from the stock's current price.
View analysts price targets for SCPH
or view top-rated stocks among Wall Street analysts.

How have SCPH shares performed in 2022?

scPharmaceuticals' stock was trading at $5.02 on January 1st, 2022. Since then, SCPH shares have increased by 41.8% and is now trading at $7.12.
View the best growth stocks for 2022 here
.

Are investors shorting scPharmaceuticals?

scPharmaceuticals saw a increase in short interest in November. As of November 15th, there was short interest totaling 597,100 shares, an increase of 23.9% from the October 31st total of 482,000 shares. Based on an average daily volume of 405,300 shares, the short-interest ratio is presently 1.5 days. Currently, 3.4% of the shares of the stock are sold short.
View scPharmaceuticals' Short Interest
.

When is scPharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 28th 2023.
View our SCPH earnings forecast
.

How were scPharmaceuticals' earnings last quarter?

scPharmaceuticals Inc. (NASDAQ:SCPH) issued its quarterly earnings data on Wednesday, November, 9th. The company reported ($0.37) earnings per share for the quarter, beating analysts' consensus estimates of ($0.41) by $0.04.

What other stocks do shareholders of scPharmaceuticals own?
When did scPharmaceuticals IPO?

(SCPH) raised $96 million in an initial public offering on Friday, November 17th 2017. The company issued 6,400,000 shares at a price of $14.00-$16.00 per share. Jefferies, Leerink Partners and BMO Capital Markets served as the underwriters for the IPO.

What is scPharmaceuticals' stock symbol?

scPharmaceuticals trades on the NASDAQ under the ticker symbol "SCPH."

Who are scPharmaceuticals' major shareholders?

scPharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional investors include Armistice Capital LLC (9.08%), Worth Venture Partners LLC (0.69%), Renaissance Technologies LLC (0.66%), Dimensional Fund Advisors LP (0.51%), Belvedere Trading LLC (0.44%) and Boothbay Fund Management LLC (0.15%). Insiders that own company stock include 5Am Partners Iv, Llc, Andrew J Schwab, Jack A Khattar, John H Tucker, Orbimed Advisors Llc and Ra Capital Management, LP.
View institutional ownership trends
.

How do I buy shares of scPharmaceuticals?

Shares of SCPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is scPharmaceuticals' stock price today?

One share of SCPH stock can currently be purchased for approximately $7.12.

How much money does scPharmaceuticals make?

scPharmaceuticals (NASDAQ:SCPH) has a market capitalization of $195.33 million. The company earns $-28,030,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis.

How can I contact scPharmaceuticals?

scPharmaceuticals' mailing address is 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA, 01830. The official website for the company is www.scpharma.com. The company can be reached via phone at (617) 517-0730 or via email at tignelzi@scpharma.com.

This page (NASDAQ:SCPH) was last updated on 12/1/2022 by MarketBeat.com Staff